Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 189,881 shares of the company's stock, valued at approximately $6,636,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.12% of Option Care Health at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of OPCH. Murphy & Mullick Capital Management Corp purchased a new position in shares of Option Care Health during the fourth quarter worth about $26,000. Bessemer Group Inc. boosted its holdings in Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after purchasing an additional 599 shares in the last quarter. Quadrant Capital Group LLC boosted its holdings in Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after purchasing an additional 1,099 shares in the last quarter. Public Employees Retirement System of Ohio grew its holdings in shares of Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after acquiring an additional 332 shares during the period. Finally, Wealthquest Corp acquired a new stake in shares of Option Care Health in the 1st quarter worth approximately $66,000. Hedge funds and other institutional investors own 98.05% of the company's stock.
Option Care Health Stock Up 1.7%
Shares of Option Care Health stock traded up $0.51 during trading hours on Wednesday, hitting $30.64. 3,960,430 shares of the company's stock traded hands, compared to its average volume of 1,215,008. The stock has a 50 day simple moving average of $31.16 and a 200-day simple moving average of $31.95. The company has a quick ratio of 1.02, a current ratio of 1.54 and a debt-to-equity ratio of 0.82. The company has a market cap of $5.02 billion, a PE ratio of 24.71, a PEG ratio of 1.96 and a beta of 0.73. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53.
Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The business had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. During the same period last year, the firm earned $0.26 earnings per share. The company's revenue for the quarter was up 16.3% compared to the same quarter last year. Equities research analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities research analysts recently issued reports on OPCH shares. JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research note on Wednesday, June 18th. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and increased their target price for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research report on Thursday, July 10th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, Option Care Health has an average rating of "Moderate Buy" and an average price target of $35.50.
Read Our Latest Analysis on OPCH
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.